Biohaven Statistics

Total Valuation

Biohaven has a market cap or net worth of $1.45 billion. The enterprise value is $1.41 billion.

Market Cap	1.45B
Enterprise Value	1.41B

Important Dates

The next estimated earnings date is Monday, May 11, 2026, after market close.

Earnings Date	May 11, 2026
Ex-Dividend Date	n/a

Share Statistics

Biohaven has 150.42 million shares outstanding. The number of shares has increased by 17.97% in one year.

Current Share Class	150.42M
Shares Outstanding	150.42M
Shares Change (YoY)	+17.97%
Shares Change (QoQ)	+13.58%
Owned by Insiders (%)	10.82%
Owned by Institutions (%)	85.39%
Float	123.86M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	283.40
PB Ratio	24.50
P/TBV Ratio	44.78
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.18, with a Debt / Equity ratio of 5.47.

Current Ratio	3.18
Quick Ratio	2.75
Debt / Equity	5.47
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -310.75% and return on invested capital (ROIC) is -111.14%.

Return on Equity (ROE)	-310.75%
Return on Assets (ROA)	-83.02%
Return on Invested Capital (ROIC)	-111.14%
Return on Capital Employed (ROCE)	-211.13%
Weighted Average Cost of Capital (WACC)	20.18%
Revenue Per Employee	n/a
Profits Per Employee	-$2.70M
Employee Count	274
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Biohaven has paid $1.44 million in taxes.

Income Tax	1.44M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.56% in the last 52 weeks. The beta is 3.62, so Biohaven's price volatility has been higher than the market average.

Beta (5Y)	3.62
52-Week Price Change	-51.56%
50-Day Moving Average	10.03
200-Day Moving Average	12.33
Relative Strength Index (RSI)	46.60
Average Volume (20 Days)	2,013,630

Short Selling Information

The latest short interest is 23.78 million, so 15.81% of the outstanding shares have been sold short.

Short Interest	23.78M
Short Previous Month	21.90M
Short % of Shares Out	15.81%
Short % of Float	19.20%
Short Ratio (days to cover)	10.55

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-708.37M
Pretax Income	-737.38M
Net Income	-738.82M
EBITDA	-698.45M
EBIT	-708.37M
Earnings Per Share (EPS)	-$6.86

Full Income Statement

Balance Sheet

The company has $319.14 million in cash and $284.61 million in debt, giving a net cash position of $34.52 million or $0.23 per share.

Cash & Cash Equivalents	319.14M
Total Debt	284.61M
Net Cash	34.52M
Net Cash Per Share	$0.23
Equity (Book Value)	52.07M
Book Value Per Share	0.39
Working Capital	252.40M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$609.44 million and capital expenditures -$715,000, giving a free cash flow of -$610.15 million.

Operating Cash Flow	-609.44M
Capital Expenditures	-715,000
Depreciation & Amortization	9.92M
Net Borrowing	250.00M
Free Cash Flow	-610.15M
FCF Per Share	-$4.06

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Biohaven does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.97%
Shareholder Yield	-17.97%
Earnings Yield	-51.11%
FCF Yield	-42.21%

Analyst Forecast

The average price target for Biohaven is $29.08, which is 202.60% higher than the current price. The consensus rating is "Buy".

Price Target	$29.08
Price Target Difference	202.60%
Analyst Consensus	Buy
Analyst Count	14
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1